We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current T1EV34 market cap is 53.46B. The company's latest EPS is USD -1.4455 and P/E is -11.41.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.46B | 3.82B | 4.16B | 4.33B | 4.23B |
| Operating Income | 697M | -216M | -7M | -50M | 997M |
| Net Income | 429M | -139M | -846M | -437M | -217M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 16.66B | 15.88B | 14.93B | 15.85B | 16.54B |
| Operating Income | -3.58B | 1.71B | -2.12B | 408M | 724M |
| Net Income | -3.99B | 417M | -2.35B | -559M | -1.64B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 43.48B | 42.77B | 41.34B | 41.76B | 39.33B |
| Total Liabilities | 35.35B | 35.23B | 34.78B | 35.38B | 33.61B |
| Total Equity | 8.13B | 7.54B | 6.56B | 6.38B | 5.38B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 50.64B | 47.67B | 44.01B | 43.48B | 39.33B |
| Total Liabilities | 39.58B | 36.42B | 35.32B | 35.35B | 33.61B |
| Total Equity | 11.06B | 11.24B | 8.69B | 8.13B | 5.38B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.37B | -124M | -21M | 672M | 1.25B |
| Investing | 968M | 144M | 322M | 590M | 792M |
| Financing | -1.91B | -152M | -1.12B | -1.12B | -1.79B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.22B | 798M | 1.59B | 1.37B | 1.25B |
| Investing | 863M | 1.52B | 656M | 968M | 792M |
| Financing | -1.89B | -2.17B | -1.49B | -1.91B | -1.79B |
| Market Cap | 53.46B |
| Price to Earnings Ratio | -11.41 |
| Price to Sales Ratio | 1.13 |
| Price to Cash Ratio | 5.67 |
| Price to Book Ratio | 3.27 |
| Dividend Yield | - |
| Shares Outstanding | 1.13B |
| Average Volume (1 week) | 35 |
| Average Volume (1 Month) | 133 |
| 52 Week Change | 45.12% |
| 52 Week High | 70.28 |
| 52 Week Low | 32.34 |
| Spread (Intraday) | 0.25 (0.53%) |
| Company Name | Teva- Pharmaceutical Industries Ltd. |
| Address |
124 dvora hanevi’a st tel aviv, center 6944020 |
| Website | https://www.tevapharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
